HRN01

Main objectives: 1. To evaluate the safety and tolerability of HRN01 tablets after single and multiple oral administration in healthy subjects; 2. To evaluate the effect of food (high-fat and high-calorie meal) on the pharmacokinetics of HRN01 tablets. Secondary objectives: 1. To evaluate the pharmacokinetic characteristics of HRN01 tablets after single and multiple oral administration in healthy subjects; 2. To evaluate the metabolism and excretion characteristics of HRN01 tablets in healthy subjects; 3. To evaluate the effect of single administration of HRN01 tablets on the QTc interval of healthy subjects; 4. To evaluate the safety and tolerability of oral administration of HRN01 tablets in healthy subjects in the postprandial state (high-fat and high-calorie meal). Exploratory objectives: To explore the pharmacodynamic indicators of HRN01 tablets after multiple oral administration in healthy subjects.